Ratio between proMMP and active MMP was studied in the dynamics of growth of the Lewis lung adenocarcinoma with lung metastasis. It was shown that tumor growth is associated with an increase in the content of proMMP (day 20; terminal stage), but the level of active MMP in tumor tissue did not signifi cantly change. The development of lung metastasis was accompanied by accumulation of active MMP (days 7, 15, and 20) and a decrease in the content of pro-MMP (days 7, and 20) in comparison with the control. In the spleen of these mice (metastasis-free organ), an increase in the levels of proMMP (day 20) and especially active MMP (days 7, 15, and 20) were found. The results suggest that tumor development shifts the proportion between active MMP and proenzymes in the tumor, lungs with metastasis, and spleen without metastasis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ya. Kisarova and T. A. Korolenko, Bull. Exp. Biol. Med., 153, No. 6, 875-878 (2012).
V. I. Kaledin, N. A. Zhukova, V. P. Nikolin, et al., Bull. Exp. Biol. Med., 148, No. 6, 903-907 (2010).
E. Bailón, E. Ugarte-Berzal, I. Amigo-Jiménez, et al., J. Leukoc. Biol., 96, No. 2, 185-199 (2014).
K. Brew and Н. Nagase, Biochim. Biophys. Acta, 1803, No. 1, 55-71 (2010).
V. Hofmeister, D. Schrama, and J. C. Becker, Cancer Immunol. Immunother., 57, No. 1, 1-17 (2008).
Y. Itoh, N. Ito, H. Nagase, and M. Seiki, J. Biol. Chem., 283, No. 19, 13 053-13 062 (2008).
K. L. Kessenbrock, V. Plaks, and Z. Werb, Cell, 141, No. 1, 52-67 (2010).
T. A. Korolenko, F. V. Tuzikov, M. S. Cherkanova, et al., Can. J. Physiol. Pharmacol., 90, No. 2, 141-153 (2012).
T. A. Korolenko, I. G. Svechnikova, E. E. Filjushina, et al., Drugs Exp. Clin. Res., 24, Nos. 5-6, 253-260 (1998).
T. A. Korolenko, E. V. Rukavishnikova, A. F. Safina, et al., Biol. Chem. Hoppe Seyler., 373, No. 7, 573-580 (1992).
S. C. Liu, S. F. Yang, K. T. Yeh, et al., Clin. Chim. Acta, 371, Nos. 1-2, 92-96 (2006).
T. R. Patel, G. Butler, A. McFarlane, et al., PLoS One, 7, No. 9, e43669, doi: 10.1371/journal.pone.0043669 (2012).
J. A. Rodriguez, T. Sobrino, J. Orbe, et al., J. Thromb. Haemost., 11, No. 8, 1464-1473 (2013).
A. F. Safi na, T. A. Korolenko, G. I. Mynkina, et al., Agents Actions., 38, Pt 3, 370-375 (1992).
J. Vandooren, P. E. Van den Steen, and G. Opdenakker, Crit. Rev. Biochem. Mol. Biol., 48, No. 3, 222-272 (2013).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 159, No. 4, pp. 481-485, April, 2015
Rights and permissions
About this article
Cite this article
Kisarova, Y.A., Kaledin, V.I., Bogdanova, L.A. et al. Ratio of Active Matrix Metalloproteinases and Proenzymes during Growth and Metastasizing of Mouse Lewis Lung Adenocarcinoma. Bull Exp Biol Med 159, 486–489 (2015). https://doi.org/10.1007/s10517-015-2999-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-015-2999-1